These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16586234

  • 1. Risk of third-trimester amniocentesis: a case-control study.
    Hodor JG, Poggi SH, Spong CY, Goodwin KM, Vink JS, Pezzullo JC, Ghidini A.
    Am J Perinatol; 2006 Apr; 23(3):177-80. PubMed ID: 16586234
    [Abstract] [Full Text] [Related]

  • 2. Risks of third-trimester amniocentesis.
    Zalud I, Janas S.
    J Reprod Med; 2008 Jan; 53(1):45-8. PubMed ID: 18251361
    [Abstract] [Full Text] [Related]

  • 3. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E, Tütüncü L, Muhcu M, Yergök YZ.
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss].
    Picone O, Fuchs F, Sénat MV, Brisset S, Tachdjian G, Audibert F, Fernandez H, Frydman R.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):385-91. PubMed ID: 18191913
    [Abstract] [Full Text] [Related]

  • 5. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis.
    Borgida AF, Mills AA, Feldman DM, Rodis JF, Egan JF.
    Am J Obstet Gynecol; 2000 Oct; 183(4):937-9. PubMed ID: 11035342
    [Abstract] [Full Text] [Related]

  • 6. Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis?
    Picone O, Senat MV, Rosenblatt J, Audibert F, Tachdjian G, Frydman R.
    Fetal Diagn Ther; 2008 Oct; 23(1):30-5. PubMed ID: 17934295
    [Abstract] [Full Text] [Related]

  • 7. Amniocentesis and the management of premature labor.
    Leigh J, Garite TJ.
    Obstet Gynecol; 1986 Apr; 67(4):500-6. PubMed ID: 3960420
    [Abstract] [Full Text] [Related]

  • 8. Idiopathic bleeding during the second half of pregnancy as a risk factor for adverse perinatal outcome.
    Harlev A, Levy A, Zaulan Y, Koifman A, Mazor M, Wiznitzer A, Faizayev E, Sheiner E.
    J Matern Fetal Neonatal Med; 2008 May; 21(5):331-5. PubMed ID: 18446661
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, Lau TK.
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [Abstract] [Full Text] [Related]

  • 10. Amniocentesis in the third trimester of pregnancy.
    O'Donoghue K, Giorgi L, Pontello V, Pasquini L, Kumar S.
    Prenat Diagn; 2007 Nov; 27(11):1000-4. PubMed ID: 17636852
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes with premature rupture of membranes at 32 or 33 weeks when management is based on evaluation of fetal lung maturity.
    Edwards R, Stickler L, Johnson I, Duff P.
    J Matern Fetal Neonatal Med; 2004 Nov; 16(5):281-5. PubMed ID: 15621544
    [Abstract] [Full Text] [Related]

  • 13. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios.
    Leung WC, Jouannic JM, Hyett J, Rodeck C, Jauniaux E.
    Ultrasound Obstet Gynecol; 2004 Feb; 23(2):154-8. PubMed ID: 14770396
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?
    Ovalle A, Romero R, Gómez R, Martínez MA, Nien JK, Ferrand P, Aspillaga C, Figueroa J.
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):453-64. PubMed ID: 16966109
    [Abstract] [Full Text] [Related]

  • 15. Continuous fetal monitoring following third-trimester amniocentesis.
    Klein SA, Young BK, Wilson SJ, Katz M.
    Obstet Gynecol; 1981 Oct; 58(4):444-9. PubMed ID: 7279338
    [Abstract] [Full Text] [Related]

  • 16. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies.
    Simhan HN, Canavan TP.
    BJOG; 2005 Mar; 112 Suppl 1():32-7. PubMed ID: 15715592
    [Abstract] [Full Text] [Related]

  • 17. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
    Dundar O, Yoruk P, Tutuncu L, Muhcu M, Ipcioglu O, Ergur AR, Mungen E.
    Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
    [Abstract] [Full Text] [Related]

  • 18. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
    Vrachnis N, Malamitsi-Puchner A, Samoli E, Botsis D, Iliodromiti Z, Baka S, Hassiakos D, Creatsas G.
    J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients.
    Dudhbhai M, Lim L, Bombard A, Juliard K, Meenakshi B, Trachelenberg Y, Weiner Z.
    Am J Obstet Gynecol; 2006 May; 194(5):e42-5. PubMed ID: 16647897
    [Abstract] [Full Text] [Related]

  • 20. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
    Gortzak-Uzan L, Mezad D, Smolin A, Friger M, Huleihel M, Hallak M.
    J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.